Amgen (AMGN) Non Operating Income (2009 - 2026)

Amgen has reported Non Operating Income for 18 years, with the latest figure at $75.0 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 95.06% year-over-year to $75.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (down 46.53% YoY), and the FY2025 full-year result was $2.7 billion, up 423.91% from the prior year.
• Non Operating Income for Q1 2026 stood at $75.0 million, up from -$553.0 million in the prior quarter.
• The five-year high for Non Operating Income was $2.1 billion in Q3 2025, with the low at -$782.0 million in Q4 2024.
• Average Non Operating Income over 5 years is $308.9 million, with a median of -$67.0 million recorded in 2022.
• Year-over-year, Non Operating Income sank 4176.92% in 2022 and jumped 745.96% in 2025.
• Tracing AMGN's Non Operating Income over 5 years: stood at -$67.0 million in 2022, then soared by 700.0% to $402.0 million in 2023, then plunged by 294.53% to -$782.0 million in 2024, then gained by 29.28% to -$553.0 million in 2025, then surged by 113.56% to $75.0 million in 2026.
• The last three Non Operating Income figures came in at $75.0 million (Q1 2026), -$553.0 million (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.

Peer Comparison